BAP Ex-Officio Member Details

Chair of the Psychopharmacology Committee of the Royal College of Psychiatrists

Professor David Baldwin

David Baldwin

University of Southampton

Professor of Psychiatry in the Clinical and Experimental Sciences Academic Unit of the Faculty of Medicine at the University of Southampton, an Honorary Professor in the University of Cape Town in South Africa and Visiting Professor at Shandong Mental Health Centre at Jinan in China. Trained in medicine at Charing Cross Hospital Medical School, in psychiatry at St Mary's Hospital Medical School and the Maudsley Hospital, and in medical humanities at Birkbeck College. Current Chair of the Psychopharmacology Committee of the Royal College of Psychiatrists and Clinical Advisor to the National Clinical Audit of Anxiety and Depression, a Past President of Depression Alliance, a Medical Patron of Anxiety UK, a previous Secretary for External Affairs of the British Association for Psychopharmacology, and Editor-in-Chief of Human Psychopharmacology.

Aims to improve outcomes in mood and anxiety disorders: by investigating the role of neurobiological and psychological factors in causing and maintaining illness; through improving trial design when evaluating efficacy and tolerability of treatment interventions; by assessing the effectiveness and acceptability of treatment interventions in wider clinical practice; through identifying more accurately those patient groups at particular risk of poor outcomes; and by offering a tertiary referral specialist clinical service to patients with treatment-resistant conditions.

Declaration of Interests

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No
  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No
  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No
  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. H. Lundbeck A/S, Liva Nova, Mundipharma.
  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No
  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No
  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No
  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. AstraZeneca, Janssen, H. Lundbeck A/s
  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No
  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No
  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. Medical Patron of Anxiety UK.

Form completed on 23rd July 2019